PatentBrief · Patent BriefUS 10702600
Betacoronavirus mRNA vaccine
The disclosure relates to respiratory virus ribonucleic acid (RNA) vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
Patent Number
US 10702600
Status
Active
Filing Date
February 28, 2020
Grant Date
July 7, 2020
Expiration
~February 2040 (estimated)
Claims
30
Assignee
ModernaTx Inc
Inventors
Giuseppe Ciaramella, Sunny Himansu
Citations
46 forward · 253 backward
What it covers
The disclosure relates to respiratory virus ribonucleic acid (RNA) vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
Generated by PatentBrief · Not legal advice · patentbrief.org
US 10702600 · 2026